Stocks
Tectonic Therapeutic, Inc.TECX
NASDAQHealthcareBiotechnology$20.07
Price as of · delayed, not real-time
A clinical-stage biopharmaceutical company developing novel therapeutics for G protein-coupled receptor (GPCR) targets, with a focus on conditions with high unmet medical need. Its lead programs include a selective agonist for pulmonary arterial hypertension and other candidates in fibrosis and metabolic indications. Investors track the company for its proprietary platform and pipeline readouts from mid-stage trials.
52W Range: $15.52-$39.53
Congressional Interest in Tectonic Therapeutic, Inc. (TECX)
No congressional trades have been disclosed for Tectonic Therapeutic, Inc. (TECX) yet. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
Total Disclosures
0
Unique Politicians
0
Buys
0
Sells
0
Who in Congress Is Trading TECX?
No congressional trades found for this stock.